EIF4G1 and non-small cell lung carcinoma: Moreover, most of NSCLC cases with positive for EIF4G1 expression (++ ~ ++++) were also positive for PD‐1 (53.3%, 24/45) and/or PD‐L1 (91.1%, 41/45).